Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Hematopoietic cell transplantation can be safely performed after COVID-19

Bone Marrow Transplantation volume 58, pages 1410–1412 (2023)Cite this article

Subjects

COVID-19 during hematopoietic cell transplantation (HCT) results in worse outcomes [1]. However, the impact of COVID-19 before HCT is not well studied. We present the experience at our center with HCT after COVID-19.

We included 21 consecutive patients who received allogeneic (n = 13) or autologous (n = 8) HCT following COVID-19 between July 2020 through April 2021. Data were extracted from electronic medical records and BMTWeb (in-house database). Pulmonary function testing (PFT) was done post-COVID and pre-and post-allogeneic-HCT. COVID-19 testing was performed before procedures or hospital admissions, and infection severity was scored using the WHO grading [2]. Overall survival (OS) was estimated by Kaplan-Meir. Repeat measures Wilcoxon test was used to compare PFTs pre- and post-HCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Meyerowitz-Katz G, Merone L. A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates. Int J Infect Dis. 2020;101:138–48. https://doi.org/10.1016/j.ijid.2020.09.1464.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis 2020;20:e192-e197. https://doi.org/10.1016/S1473-3099(20)30483-7

  3. Shah N, Dahi PB, Ponce DM, Sauter CS, Shaffer BC, Chung DJ, et al. Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection. Transpl Cell Ther. 2022;28:55.e1–55.e5. https://doi.org/10.1016/j.jtct.2021.10.004.

    Article  CAS  Google Scholar 

  4. Christopeit M, Reichard M, Niederwieser C, Massoud R, Klyuchnikov E, Haase N, et al. Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection. Bone Marrow Transpl. 2021;56:1478–81. https://doi.org/10.1038/s41409-021-01225-w.

    Article  CAS  Google Scholar 

  5. Niederwieser C, Weber B, Reichard M, Gagelmann N, Ajib S, Schlipfenbacher V, et al. Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19. Bone Marrow Transpl. 2022;57:1180–2. https://doi.org/10.1038/s41409-022-01660-3.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Alejandro Marinos, Jeremy Ramdial, Fareed Khawaja, Rima M. Saliba, Terri Lynn Shigle, Amin. M. Alousi, Gabriela Rondon, Julianne Chen, Celina Ledesma, Richard E. Champlin, May Daher, George Chen, David Marin, Katayoun Rezvani, Elizabeth J. Shpall & Roy F. Chemaly

Authors
  1. Alejandro Marinos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeremy Ramdial
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fareed Khawaja
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rima M. Saliba
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Terri Lynn Shigle
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Amin. M. Alousi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gabriela Rondon
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Julianne Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Celina Ledesma
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Richard E. Champlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. May Daher
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. George Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. David Marin
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Katayoun Rezvani
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Elizabeth J. Shpall
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Roy F. Chemaly
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AM contributed to analyzing data, interpreting results, and writing the report. JR contributed by writing the report, interpreting results, and editing. FK, ES, RC, and RFC contributed by designing the research protocol and editing the manuscript. RS contributed with statistical and data analysis. TS, AA, GR, JC, CL, MD, GC, DM, KR contributed by reviewing and giving feedback on the manuscript.

Corresponding author

Correspondence to Alejandro Marinos.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marinos, A., Ramdial, J., Khawaja, F. et al. Hematopoietic cell transplantation can be safely performed after COVID-19. Bone Marrow Transplant 58, 1410–1412 (2023). https://doi.org/10.1038/s41409-023-02105-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-023-02105-1

Search

Advanced search

Quick links